OBM Geriatrics is an Open Access journal published quarterly online by LIDSEN Publishing Inc. The journal takes the premise that innovative approaches – including gene therapy, cell therapy, and epigenetic modulation – will result in clinical interventions that alter the fundamental pathology and the clinical course of age-related human diseases. We will give strong preference to papers that emphasize an alteration (or a potential alteration) in the fundamental disease course of Alzheimer’s disease, vascular aging diseases, osteoarthritis, osteoporosis, skin aging, immune senescence, and other age-related diseases.
Geriatric medicine is now entering a unique point in history, where the focus will no longer be on palliative, ameliorative, or social aspects of care for age-related disease, but will be capable of stopping, preventing, and reversing major disease constellations that have heretofore been entirely resistant to interventions based on “small molecular” pharmacological approaches. With the changing emphasis from genetic to epigenetic understandings of pathology (including telomere biology), with the use of gene delivery systems (including viral delivery systems), and with the use of cell-based therapies (including stem cell therapies), a fatalistic view of age-related disease is no longer a reasonable clinical default nor an appropriate clinical research paradigm.
Precedence will be given to papers describing fundamental interventions, including interventions that affect cell senescence, patterns of gene expression, telomere biology, stem cell biology, and other innovative, 21st century interventions, especially if the focus is on clinical applications, ongoing clinical trials, or animal trials preparatory to phase 1 human clinical trials.
Papers must be clear and concise, but detailed data is strongly encouraged. The journal publishes research articles, reviews, communications and technical notes. There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 6 days from acceptance to publication (median values for papers published in this journal in the first half of 2019, 1-2 days of FREE language polishing time is also included in this period).
Osteoporosis in the Elderly
Submission Deadline: December 30, 2019 (Open) Submit Now
Clinical Professor, School of Health Studies and Professional Programs, Department of Health and Human Performance, York College, City University of New York, New York, NY, USA;
Lecturer, Department of Health and Behavior Studies, Program in Health Education, Teachers College, Columbia University, New York, NY, USA.
E-mail: firstname.lastname@example.org; email@example.com
Website: https://www.tc.columbia.edu/faculty/rm226/; https://www.linkedin.com/in/ray-marks-a5856b2a
Research Interests: Osteoporosis; osteoarthritis; knee osteoarthritis; falls prevention; depression; aging
About This Topic
Osteoporosis a highly common bone disease is especially prevalent among the older population. Associated with varying degrees of bone thinning, fragility, and increased susceptibility to fracture, high rates of disability as well as pain commonly ensue from this condition even in absence of fractures. Unfortunately, relatively little has been done over time to reduce the incidence and immense burden of this painful progressive disease, despite evidence that this disease and its consequences are not inevitable. This Special Edition welcomes articles that focus on this topic of osteoporosis especially from the viewpoint of prevention, as well as treatment, and early detection. Articles of any genre concerning the importance of early detection, preventing and treating geriatric osteoporosis and its correlates are specifically sought.
Tarik Wasfie, Avery Jackson III, Cara Marie Brock, Stefanija Galovska, Jennifer Hille
Received: November 07, 2019; Published: November 13, 2019; doi:10.21926/obm.geriatr.1904085